Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.
Publication
, Journal Article
Hale, GE; Hughes, CL; Cline, JM
Published in: J Clin Endocrinol Metab
January 2002
Duke Scholars
Published In
J Clin Endocrinol Metab
DOI
ISSN
0021-972X
Publication Date
January 2002
Volume
87
Issue
1
Start / End Page
3 / 15
Location
United States
Related Subject Headings
- Risk Factors
- Progesterone
- Obesity
- Longitudinal Studies
- Isoflavones
- Humans
- Hormone Replacement Therapy
- Female
- Exercise
- Estrogens
Citation
APA
Chicago
ICMJE
MLA
NLM
Hale, G. E., Hughes, C. L., & Cline, J. M. (2002). Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones. J Clin Endocrinol Metab, 87(1), 3–15. https://doi.org/10.1210/jcem.87.1.8132
Hale, G. E., C. L. Hughes, and J. M. Cline. “Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.” J Clin Endocrinol Metab 87, no. 1 (January 2002): 3–15. https://doi.org/10.1210/jcem.87.1.8132.
Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones. J Clin Endocrinol Metab. 2002 Jan;87(1):3–15.
Hale, G. E., et al. “Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.” J Clin Endocrinol Metab, vol. 87, no. 1, Jan. 2002, pp. 3–15. Pubmed, doi:10.1210/jcem.87.1.8132.
Hale GE, Hughes CL, Cline JM. Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones. J Clin Endocrinol Metab. 2002 Jan;87(1):3–15.
Published In
J Clin Endocrinol Metab
DOI
ISSN
0021-972X
Publication Date
January 2002
Volume
87
Issue
1
Start / End Page
3 / 15
Location
United States
Related Subject Headings
- Risk Factors
- Progesterone
- Obesity
- Longitudinal Studies
- Isoflavones
- Humans
- Hormone Replacement Therapy
- Female
- Exercise
- Estrogens